In this study, we hypothesized that the product of the expression of PD-L1 (TPS [%]) in lung cancer and preoperative NLR (i.e., PD-L1 × NLR) is a novel prognostic factor that reflects the immune microenvironment in lung cancer. The gene discussed is CD274; the disease is lung carcinoma.